← Back to Search

Neural Interface

Auditory Implant Evaluation for Hearing Loss

N/A

Recruiting

Led By Mahan Azadpour

Research Sponsored by NYU Langone Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Hearing impaired adult and or child (above 2 years old) who uses ABIs or cochlear implants.

No diagnosis of any other communicative or cognitive disorder other than hearing impairment. The individual must be able to visit the lab in order to participate in behavioral and electrophysiological experiments.

Must not have

Severe neurological disorders

Timeline

Screening 3 weeks

Treatment Varies

Follow Up day 1 (visit 1 - average visit length is about 3 hours)

Awards & highlights

No Placebo-Only Group

Summary

This trial will study the hearing of adults and kids with hearing impairments who use implants to hear. It will evaluate how well the implants work.

Who is the study for?

This trial is for hearing-impaired adults and children over 2 years old who use cochlear or auditory brainstem implants. Participants must not have other cognitive or communicative disorders, severe neurological issues, and their implant's electrodes must be functional without causing discomfort.

What is being tested?

The study investigates how well people with cochlear or auditory brainstem implants process sounds. It involves behavioral and electrophysiological experiments conducted in a lab setting to evaluate the effectiveness of these devices in restoring hearing functions.

What are the potential side effects?

Since this is an observational study focusing on auditory processing, there are no direct side effects from interventions like drugs or surgeries. However, participants may experience fatigue or discomfort during testing procedures.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am hearing impaired and use an ABI or cochlear implant.

Select...

I have no cognitive disorders except for hearing impairment and can visit the lab.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have a severe neurological disorder.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ day 1 (visit 1 - average visit length is about 3 hours)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~day 1 (visit 1 - average visit length is about 3 hours)

This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1 (visit 1 - average visit length is about 3 hours) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Percent of Correctly-Identified Speech Materials

Percent of Correctly-Identified Stimuli Characteristics when Two or More Stimuli are Presented

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Hearing-Impaired Individuals who use Cochlear Implants or Auditory Brainstem Implant (ABI) DevicesExperimental Treatment1 Intervention

Two types of measurements will be obtained: 1. Perceptual: one or more sounds are presented and a behavioral response is collected (e.g., judgements of loudness, pitch or other differences between the sounds, or identifying the word or sentence that was said). 2. Physiological: noninvasive electrophysiological recordings of nervous system activity.

0 / 3Eligibility criteria met